Preload Image
Preload Image
Report Store mobile icon
Global Therapeutic Vaccines Market Growth 2024-2030

Global Therapeutic Vaccines Market Growth 2024-2030

2024

Global Therapeutic Vaccines Market Growth 2024-2030

The Therapeutic Vaccines market was valued at US$ 30,360 million in 2023, and is expected to grow as demand for vaccines targeting diseases like cancer and infections rises.

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global therapeutic vaccines market is witnessing significant growth, driven by increasing disease prevalence, technological advancements, and substantial investments from major market players and government bodies. Therapeutic vaccines, which differ from traditional prophylactic vaccines, are designed for patients already suffering from diseases such as cancer, HIV, autoimmune disorders, and neurological conditions. These vaccines aim to boost the body's immune response to fight existing diseases, making them a crucial part of personalized medicine. The market includes various types of therapeutic vaccines targeting different diseases, with cancer vaccines being one of the fastest-growing segments due to the high global cancer incidence and ongoing research. North America leads the market, with the United States taking a prominent role due to its advanced healthcare infrastructure, high investment in research and development, and the presence of key players like Merck, GSK, and Pfizer. In Europe, substantial investments and strong government support propel the market, particularly in countries like Germany, France, and the UK. The Asia-Pacific region is expected to witness the fastest growth, fueled by increasing healthcare expenditure, rising disease awareness, and expanding biopharmaceutical industries in countries like China, Japan, and India. In the Middle East and Africa, improved healthcare access and modernization efforts drive market growth. Latin America, especially Brazil and Mexico, is also seeing growth due to healthcare system advancements and increased focus on innovative treatments. The market's expansion is further supported by NGOs' initiatives and patient advocacy groups, raising awareness and facilitating access to advanced therapeutics. The continuous innovation in vaccine technology, including the development of novel vaccines for diseases like breast cancer and Alzheimer's, underlines the market's potential for significant advancements.

According to Publisher, the global Therapeutic Vaccines market size was valued at US$ 30360 million in 2023. With growing demand in downstream market, the Therapeutic Vaccines is forecast to a readjusted size of US$ 117590 million by 2030 with a CAGR of 21.3% during review period. The research report highlights the growth potential of the global Therapeutic Vaccines market. Therapeutic Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Therapeutic Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Therapeutic Vaccines market. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample


The global therapeutic vaccine market is segmented by type, focusing on cancer, infectious diseases, autoimmune diseases, and neurological diseases. Cancer therapeutic vaccines hold a prominent share, driven by the high prevalence of various cancers and ongoing research and development in immunotherapy. Notable examples include Sipuleucel-T (provenge) for prostate cancer and emerging neoantigen-based vaccines that are showing promise in clinical trials. The growing incidence of cancer globally and the demand for personalized treatments fuel this segment's growth. The infectious diseases segment comprises vaccines designed to treat chronic infections such as HIV, Hepatitis B, and Hepatitis C1. Technological advancements and increased investment in vaccine research are propelling this segment forward, addressing the need for effective treatment options for persistent infections. Autoimmune disease therapeutic vaccines aim to modulate the immune system to reduce autoimmune responses. Conditions like multiple sclerosis (MS) and rheumatoid arthritis are key focus areas where therapeutic vaccines are being developed to improve patient outcomes. Neurological diseases, including Alzheimer's and Parkinson's, represent another critical segment. As understanding of these conditions improves, therapeutic vaccines are being explored to target abnormal proteins and slow disease progression. Overall, the type-based segmentation of the global therapeutic vaccine market highlights the diverse applications of these vaccines in addressing a wide range of chronic and life-threatening conditions. Increased R&D investments, advancements in immunotherapy technologies, and a growing emphasis on personalized medicine play a pivotal role in driving this market's growth. Key players like Merck, GSK, and Pfizer are at the forefront of innovation, continuously expanding their portfolios to cater to the evolving needs of patients worldwide. The collaborative efforts between biotech firms, academic institutions, and healthcare providers further enhance the potential to develop next-generation therapeutic vaccines tailored to individual patient profiles.

The global therapeutic vaccines market's application segment highlights its diverse and impactful use across various medical fields, namely oncology (cancer), infectious diseases, autoimmune diseases, and neurological disorders. In oncology, therapeutic vaccines such as Sipuleucel-T (Provenge) for prostate cancer and emerging neoantigen-based vaccines target cancer cells to enhance the immune response and slow disease progression. This application segment is driven by the high prevalence of cancer and ongoing research and development in immunotherapy. Infectious diseases application includes vaccines for persistent infections like HIV, Hepatitis B, and Hepatitis C. These vaccines stimulate the immune system to manage chronic infections, reducing virus loads and improving patient outcomes. Autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis are another critical segment. Therapeutic vaccines in this field aim to modulate the immune system, reducing autoimmune responses and fetching significant growth, especially with advancements in biomarkers and personalized medicine. Neurological disorders, including Alzheimer's and Parkinson's, represent a burgeoning area within therapeutic vaccines, aiming to target abnormal proteins and slow disease progression. The continuous advancements in vaccine technology, along with increasing R&D investments and the emphasis on personalized medicine, play a pivotal role in driving this market's growth. Key players like Merck, GSK, and Pfizer are at the forefront of innovation, expanding their portfolios to cater to the evolving needs of patients worldwide. Collaborative efforts between biotech firms, academic institutions, and healthcare providers are enhancing the potential to develop next-generation therapeutic vaccines tailored to individual patient profiles. The diverse segmentation by application underlines the critical impact of therapeutic vaccines in addressing a wide range of chronic and life-threatening conditions, ensuring robust growth and promising advancements in the coming years.

The global therapeutic vaccines market displays significant regional variation in growth, driven by diverse economic conditions, healthcare infrastructure, and technological advancements. North America leads the market, with the United States being a major contributor due to its advanced healthcare system, substantial research and development investments, and the presence of key players like Merck, GSK, and Pfizer. The high prevalence of diseases such as cancer and HIV, coupled with the robust adoption of innovative health technologies, propels market growth in this region. Europe follows closely, with countries like Germany, France, and the United Kingdom making significant investments in therapeutic vaccines, supported by comprehensive healthcare policies and strong government backing. The increasing emphasis on personalized medicine and preventive healthcare further supports market expansion in Europe 3. The Asia-Pacific region is expected to witness the fastest growth, fueled by expanding healthcare infrastructure, rising disposable incomes, and increasing awareness about therapeutic vaccines. Countries like China, Japan, and India are key contributors, benefiting from government initiatives aimed at boosting healthcare access and promoting vaccine development. In the Middle East and Africa, the market is emerging, with significant investments in healthcare modernization and increased focus on reducing the burden of chronic diseases. Countries like Saudi Arabia and the UAE are notably investing in advanced healthcare infrastructure and facilities to meet growing healthcare demands. Latin America, particularly Brazil and Mexico, is also experiencing growth driven by healthcare system advancements and increased focus on innovative treatments.


Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Sikandar Kesari

Research Analyst



Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Sikandar Kesari

Table of Contents

  • 1 Scope of the Report
  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats
  • 2 Executive Summary
  • 2.1 World Market Overview
  • 2.1.1 Global Therapeutic Vaccines Annual Sales 2019-2030
  • 2.1.2 World Current & Future Analysis for Therapeutic Vaccines by Geographic Region, 2019, 2023 & 2030
  • 2.1.3 World Current & Future Analysis for Therapeutic Vaccines by Country/Region, 2019, 2023 & 2030
  • 2.2 Therapeutic Vaccines Segment by Type
  • 2.2.1 Peptide Therapeutic Vaccine
  • 2.2.2 Cell Therapeutic Vaccine
  • 2.2.3 Nucleic Acid Therapeutic Vaccine
  • 2.3 Therapeutic Vaccines Sales by Type
  • 2.3.1 Global Therapeutic Vaccines Sales Market Share by Type (2019-2024)
  • 2.3.2 Global Therapeutic Vaccines Revenue and Market Share by Type (2019-2024)
  • 2.3.3 Global Therapeutic Vaccines Sale Price by Type (2019-2024)
  • 2.4 Therapeutic Vaccines Segment by Application
  • 2.4.1 Oncotherapy
  • 2.4.2 Hepatitis B
  • 2.4.3 Tuberculosis
  • 2.4.4 Herpes Simplex Virus
  • 2.4.5 Others
  • 2.5 Therapeutic Vaccines Sales by Application
  • 2.5.1 Global Therapeutic Vaccines Sale Market Share by Application (2019-2024)
  • 2.5.2 Global Therapeutic Vaccines Revenue and Market Share by Application (2019-2024)
  • 2.5.3 Global Therapeutic Vaccines Sale Price by Application (2019-2024)
  • 3 Global Therapeutic Vaccines by Company
  • 3.1 Global Therapeutic Vaccines Breakdown Data by Company
  • 3.1.1 Global Therapeutic Vaccines Annual Sales by Company (2019-2024)
  • 3.1.2 Global Therapeutic Vaccines Sales Market Share by Company (2019-2024)
  • 3.2 Global Therapeutic Vaccines Annual Revenue by Company (2019-2024)
  • 3.2.1 Global Therapeutic Vaccines Revenue by Company (2019-2024)
  • 3.2.2 Global Therapeutic Vaccines Revenue Market Share by Company (2019-2024)
  • 3.3 Global Therapeutic Vaccines Sale Price by Company
  • 3.4 Key Manufacturers Therapeutic Vaccines Producing Area Distribution, Sales Area, Product Type
  • 3.4.1 Key Manufacturers Therapeutic Vaccines Product Location Distribution
  • 3.4.2 Players Therapeutic Vaccines Products Offered
  • 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Therapeutic Vaccines by Geographic Region
  • 4.1 World Historic Therapeutic Vaccines Market Size by Geographic Region (2019-2024)
  • 4.1.1 Global Therapeutic Vaccines Annual Sales by Geographic Region (2019-2024)
  • 4.1.2 Global Therapeutic Vaccines Annual Revenue by Geographic Region (2019-2024)
  • 4.2 World Historic Therapeutic Vaccines Market Size by Country/Region (2019-2024)
  • 4.2.1 Global Therapeutic Vaccines Annual Sales by Country/Region (2019-2024)
  • 4.2.2 Global Therapeutic Vaccines Annual Revenue by Country/Region (2019-2024)
  • 4.3 Americas Therapeutic Vaccines Sales Growth
  • 4.4 APAC Therapeutic Vaccines Sales Growth
  • 4.5 Europe Therapeutic Vaccines Sales Growth
  • 4.6 Middle East & Africa Therapeutic Vaccines Sales Growth
  • 5 Americas
  • 5.1 Americas Therapeutic Vaccines Sales by Country
  • 5.1.1 Americas Therapeutic Vaccines Sales by Country (2019-2024)
  • 5.1.2 Americas Therapeutic Vaccines Revenue by Country (2019-2024)
  • 5.2 Americas Therapeutic Vaccines Sales by Type
  • 5.3 Americas Therapeutic Vaccines Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil
  • 6 APAC
  • 6.1 APAC Therapeutic Vaccines Sales by Region
  • 6.1.1 APAC Therapeutic Vaccines Sales by Region (2019-2024)
  • 6.1.2 APAC Therapeutic Vaccines Revenue by Region (2019-2024)
  • 6.2 APAC Therapeutic Vaccines Sales by Type
  • 6.3 APAC Therapeutic Vaccines Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan
  • 7 Europe
  • 7.1 Europe Therapeutic Vaccines by Country
  • 7.1.1 Europe Therapeutic Vaccines Sales by Country (2019-2024)
  • 7.1.2 Europe Therapeutic Vaccines Revenue by Country (2019-2024)
  • 7.2 Europe Therapeutic Vaccines Sales by Type
  • 7.3 Europe Therapeutic Vaccines Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia
  • 8 Middle East & Africa
  • 8.1 Middle East & Africa Therapeutic Vaccines by Country
  • 8.1.1 Middle East & Africa Therapeutic Vaccines Sales by Country (2019-2024)
  • 8.1.2 Middle East & Africa Therapeutic Vaccines Revenue by Country (2019-2024)
  • 8.2 Middle East & Africa Therapeutic Vaccines Sales by Type
  • 8.3 Middle East & Africa Therapeutic Vaccines Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends
  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis
  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Therapeutic Vaccines
  • 10.3 Manufacturing Process Analysis of Therapeutic Vaccines
  • 10.4 Industry Chain Structure of Therapeutic Vaccines
  • 11 Marketing, Distributors and Customer
  • 11.1 Sales Channel
  • 11.1.1 Direct Channels
  • 11.1.2 Indirect Channels
  • 11.2 Therapeutic Vaccines Distributors
  • 11.3 Therapeutic Vaccines Customer
  • 12 World Forecast Review for Therapeutic Vaccines by Geographic Region
  • 12.1 Global Therapeutic Vaccines Market Size Forecast by Region
  • 12.1.1 Global Therapeutic Vaccines Forecast by Region (2025-2030)
  • 12.1.2 Global Therapeutic Vaccines Annual Revenue Forecast by Region (2025-2030)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Therapeutic Vaccines Forecast by Type
  • 12.7 Global Therapeutic Vaccines Forecast by Application
  • 13 Key Players Analysis
  • 13.1 Northeast Biotherapeutics
  • 13.1.1 Northeast Biotherapeutics Company Information
  • 13.1.2 Northeast Biotherapeutics Therapeutic Vaccines Product Portfolios and Specifications
  • 13.1.3 Northeast Biotherapeutics Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.1.4 Northeast Biotherapeutics Main Business Overview
  • 13.1.5 Northeast Biotherapeutics Latest Developments
  • 13.2 Agenus
  • 13.2.1 Agenus Company Information
  • 13.2.2 Agenus Therapeutic Vaccines Product Portfolios and Specifications
  • 13.2.3 Agenus Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.2.4 Agenus Main Business Overview
  • 13.2.5 Agenus Latest Developments
  • 13.3 Vaccinogen Inc
  • 13.3.1 Vaccinogen Inc Company Information
  • 13.3.2 Vaccinogen Inc Therapeutic Vaccines Product Portfolios and Specifications
  • 13.3.3 Vaccinogen Inc Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.3.4 Vaccinogen Inc Main Business Overview
  • 13.3.5 Vaccinogen Inc Latest Developments
  • 13.4 CIMAB S.A
  • 13.4.1 CIMAB S.A Company Information
  • 13.4.2 CIMAB S.A Therapeutic Vaccines Product Portfolios and Specifications
  • 13.4.3 CIMAB S.A Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.4.4 CIMAB S.A Main Business Overview
  • 13.4.5 CIMAB S.A Latest Developments
  • 13.5 Dendreon
  • 13.5.1 Dendreon Company Information
  • 13.5.2 Dendreon Therapeutic Vaccines Product Portfolios and Specifications
  • 13.5.3 Dendreon Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.5.4 Dendreon Main Business Overview
  • 13.5.5 Dendreon Latest Developments
  • 13.6 Corixa
  • 13.6.1 Corixa Company Information
  • 13.6.2 Corixa Therapeutic Vaccines Product Portfolios and Specifications
  • 13.6.3 Corixa Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.6.4 Corixa Main Business Overview
  • 13.6.5 Corixa Latest Developments
  • 13.7 AVAX Technologies
  • 13.7.1 AVAX Technologies Company Information
  • 13.7.2 AVAX Technologies Therapeutic Vaccines Product Portfolios and Specifications
  • 13.7.3 AVAX Technologies Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.7.4 AVAX Technologies Main Business Overview
  • 13.7.5 AVAX Technologies Latest Developments
  • 14 Research Findings and Conclusion


Table 1. Therapeutic Vaccines Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Therapeutic Vaccines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Peptide Therapeutic Vaccine
Table 4. Major Players of Cell Therapeutic Vaccine
Table 5. Major Players of Nucleic Acid Therapeutic Vaccine
Table 6. Global Therapeutic Vaccines Sales by Type (2019-2024) & (K Units)
Table 7. Global Therapeutic Vaccines Sales Market Share by Type (2019-2024)
Table 8. Global Therapeutic Vaccines Revenue by Type (2019-2024) & ($ million)
Table 9. Global Therapeutic Vaccines Revenue Market Share by Type (2019-2024)
Table 10. Global Therapeutic Vaccines Sale Price by Type (2019-2024) & (USD/Unit)
Table 11. Global Therapeutic Vaccines Sales by Application (2019-2024) & (K Units)
Table 12. Global Therapeutic Vaccines Sales Market Share by Application (2019-2024)
Table 13. Global Therapeutic Vaccines Revenue by Application (2019-2024)
Table 14. Global Therapeutic Vaccines Revenue Market Share by Application (2019-2024)
Table 15. Global Therapeutic Vaccines Sale Price by Application (2019-2024) & (USD/Unit)
Table 16. Global Therapeutic Vaccines Sales by Company (2019-2024) & (K Units)
Table 17. Global Therapeutic Vaccines Sales Market Share by Company (2019-2024)
Table 18. Global Therapeutic Vaccines Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Therapeutic Vaccines Revenue Market Share by Company (2019-2024)
Table 20. Global Therapeutic Vaccines Sale Price by Company (2019-2024) & (USD/Unit)
Table 21. Key Manufacturers Therapeutic Vaccines Producing Area Distribution and Sales Area
Table 22. Players Therapeutic Vaccines Products Offered
Table 23. Therapeutic Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Therapeutic Vaccines Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Therapeutic Vaccines Sales Market Share Geographic Region (2019-2024)
Table 28. Global Therapeutic Vaccines Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Therapeutic Vaccines Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Therapeutic Vaccines Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Therapeutic Vaccines Sales Market Share by Country/Region (2019-2024)
Table 32. Global Therapeutic Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Therapeutic Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Therapeutic Vaccines Sales by Country (2019-2024) & (K Units)
Table 35. Americas Therapeutic Vaccines Sales Market Share by Country (2019-2024)
Table 36. Americas Therapeutic Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Therapeutic Vaccines Revenue Market Share by Country (2019-2024)
Table 38. Americas Therapeutic Vaccines Sales by Type (2019-2024) & (K Units)
Table 39. Americas Therapeutic Vaccines Sales by Application (2019-2024) & (K Units)
Table 40. APAC Therapeutic Vaccines Sales by Region (2019-2024) & (K Units)
Table 41. APAC Therapeutic Vaccines Sales Market Share by Region (2019-2024)
Table 42. APAC Therapeutic Vaccines Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Therapeutic Vaccines Revenue Market Share by Region (2019-2024)
Table 44. APAC Therapeutic Vaccines Sales by Type (2019-2024) & (K Units)
Table 45. APAC Therapeutic Vaccines Sales by Application (2019-2024) & (K Units)
Table 46. Europe Therapeutic Vaccines Sales by Country (2019-2024) & (K Units)
Table 47. Europe Therapeutic Vaccines Sales Market Share by Country (2019-2024)
Table 48. Europe Therapeutic Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Therapeutic Vaccines Revenue Market Share by Country (2019-2024)
Table 50. Europe Therapeutic Vaccines Sales by Type (2019-2024) & (K Units)
Table 51. Europe Therapeutic Vaccines Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Therapeutic Vaccines Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Therapeutic Vaccines Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Therapeutic Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Therapeutic Vaccines Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Therapeutic Vaccines Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Therapeutic Vaccines Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Therapeutic Vaccines
Table 59. Key Market Challenges & Risks of Therapeutic Vaccines
Table 60. Key Industry Trends of Therapeutic Vaccines
Table 61. Therapeutic Vaccines Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Therapeutic Vaccines Distributors List
Table 64. Therapeutic Vaccines Customer List
Table 65. Global Therapeutic Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Therapeutic Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Therapeutic Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Therapeutic Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Therapeutic Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Therapeutic Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Therapeutic Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Therapeutic Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Therapeutic Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Therapeutic Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Therapeutic Vaccines Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Therapeutic Vaccines Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Therapeutic Vaccines Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Therapeutic Vaccines Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Northeast Biotherapeutics Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 80. Northeast Biotherapeutics Therapeutic Vaccines Product Portfolios and Specifications
Table 81. Northeast Biotherapeutics Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Northeast Biotherapeutics Main Business
Table 83. Northeast Biotherapeutics Latest Developments
Table 84. Agenus Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 85. Agenus Therapeutic Vaccines Product Portfolios and Specifications
Table 86. Agenus Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Agenus Main Business
Table 88. Agenus Latest Developments
Table 89. Vaccinogen Inc Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 90. Vaccinogen Inc Therapeutic Vaccines Product Portfolios and Specifications
Table 91. Vaccinogen Inc Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Vaccinogen Inc Main Business
Table 93. Vaccinogen Inc Latest Developments
Table 94. CIMAB S.A Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. CIMAB S.A Therapeutic Vaccines Product Portfolios and Specifications
Table 96. CIMAB S.A Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. CIMAB S.A Main Business
Table 98. CIMAB S.A Latest Developments
Table 99. Dendreon Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. Dendreon Therapeutic Vaccines Product Portfolios and Specifications
Table 101. Dendreon Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Dendreon Main Business
Table 103. Dendreon Latest Developments
Table 104. Corixa Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 105. Corixa Therapeutic Vaccines Product Portfolios and Specifications
Table 106. Corixa Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Corixa Main Business
Table 108. Corixa Latest Developments
Table 109. AVAX Technologies Basic Information, Therapeutic Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 110. AVAX Technologies Therapeutic Vaccines Product Portfolios and Specifications
Table 111. AVAX Technologies Therapeutic Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. AVAX Technologies Main Business
Table 113. AVAX Technologies Latest Developments
List of


Figure 1. Picture of Therapeutic Vaccines
Figure 2. Therapeutic Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Therapeutic Vaccines Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Therapeutic Vaccines Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Therapeutic Vaccines Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Peptide Therapeutic Vaccine
Figure 10. Product Picture of Cell Therapeutic Vaccine
Figure 11. Product Picture of Nucleic Acid Therapeutic Vaccine
Figure 12. Global Therapeutic Vaccines Sales Market Share by Type in 2023
Figure 13. Global Therapeutic Vaccines Revenue Market Share by Type (2019-2024)
Figure 14. Therapeutic Vaccines Consumed in Oncotherapy
Figure 15. Global Therapeutic Vaccines Market: Oncotherapy (2019-2024) & (K Units)
Figure 16. Therapeutic Vaccines Consumed in Hepatitis B
Figure 17. Global Therapeutic Vaccines Market: Hepatitis B (2019-2024) & (K Units)
Figure 18. Therapeutic Vaccines Consumed in Tuberculosis
Figure 19. Global Therapeutic Vaccines Market: Tuberculosis (2019-2024) & (K Units)
Figure 20. Therapeutic Vaccines Consumed in Herpes Simplex Virus
Figure 21. Global Therapeutic Vaccines Market: Herpes Simplex Virus (2019-2024) & (K Units)
Figure 22. Therapeutic Vaccines Consumed in Others
Figure 23. Global Therapeutic Vaccines Market: Others (2019-2024) & (K Units)
Figure 24. Global Therapeutic Vaccines Sales Market Share by Application (2023)
Figure 25. Global Therapeutic Vaccines Revenue Market Share by Application in 2023
Figure 26. Therapeutic Vaccines Sales Market by Company in 2023 (K Units)
Figure 27. Global Therapeutic Vaccines Sales Market Share by Company in 2023
Figure 28. Therapeutic Vaccines Revenue Market by Company in 2023 ($ Million)
Figure 29. Global Therapeutic Vaccines Revenue Market Share by Company in 2023
Figure 30. Global Therapeutic Vaccines Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global Therapeutic Vaccines Revenue Market Share by Geographic Region in 2023
Figure 32. Americas Therapeutic Vaccines Sales 2019-2024 (K Units)
Figure 33. Americas Therapeutic Vaccines Revenue 2019-2024 ($ Millions)
Figure 34. APAC Therapeutic Vaccines Sales 2019-2024 (K Units)
Figure 35. APAC Therapeutic Vaccines Revenue 2019-2024 ($ Millions)
Figure 36. Europe Therapeutic Vaccines Sales 2019-2024 (K Units)
Figure 37. Europe Therapeutic Vaccines Revenue 2019-2024 ($ Millions)
Figure 38. Middle East & Africa Therapeutic Vaccines Sales 2019-2024 (K Units)
Figure 39. Middle East & Africa Therapeutic Vaccines Revenue 2019-2024 ($ Millions)
Figure 40. Americas Therapeutic Vaccines Sales Market Share by Country in 2023
Figure 41. Americas Therapeutic Vaccines Revenue Market Share by Country in 2023
Figure 42. Americas Therapeutic Vaccines Sales Market Share by Type (2019-2024)
Figure 43. Americas Therapeutic Vaccines Sales Market Share by Application (2019-2024)
Figure 44. United States Therapeutic Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 45. Canada Therapeutic Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 46. Mexico Therapeutic Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 47. Brazil Therapeutic Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 48. APAC Therapeutic Vaccines Sales Market Share by Region in 2023
Figure 49. APAC Therapeutic Vaccines Revenue Market Share by Regions in 2023
Figure 50. APAC Therapeutic Vaccines Sales Market Share by Type (2019-2024)
Figure 51. APAC Therapeutic Vaccines Sales Market Share by Application (2019-2024)
Figure 52. China Therapeutic Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 53. Japan Therapeutic Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 54. South Korea Therapeutic Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 55. Southeast Asia Therapeutic Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 56. India Therapeutic Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 57. Australia Therapeutic Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 58. China Taiwan Therapeutic Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 59. Europe Therapeutic Vaccines Sales Market Share by Country in 2023
Figure 60. Europe Therapeutic Vaccines Revenue Market Share by Country in 2023
Figure 61. Europe Therapeutic Vaccines Sales Market Share by Type (2019-2024)
Figure 62. Europe Therapeutic Vaccines Sales Market Share by Application (2019-2024)
Figure 63. Germany Therapeutic Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 64. France Therapeutic Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 65. UK Therapeutic Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 66. Italy Therapeutic Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 67. Russia Therapeutic Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 68. Middle East & Africa Therapeutic Vaccines Sales Market Share by Country in 2023
Figure 69. Middle East & Africa Therapeutic Vaccines Revenue Market Share by Country in 2023
Figure 70. Middle East & Africa Therapeutic Vaccines Sales Market Share by Type (2019-2024)
Figure 71. Middle East & Africa Therapeutic Vaccines Sales Market Share by Application (2019-2024)
Figure 72. Egypt Therapeutic Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 73. South Africa Therapeutic Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 74. Israel Therapeutic Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 75. Turkey Therapeutic Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 76. GCC Country Therapeutic Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Therapeutic Vaccines in 2023
Figure 78. Manufacturing Process Analysis of Therapeutic Vaccines
Figure 79. Industry Chain Structure of Therapeutic Vaccines
Figure 80. Channels of Distribution
Figure 81. Global Therapeutic Vaccines Sales Market Forecast by Region (2025-2030)
Figure 82. Global Therapeutic Vaccines Revenue Market Share Forecast by Region (2025-2030)
Figure 83. Global Therapeutic Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 84. Global Therapeutic Vaccines Revenue Market Share Forecast by Type (2025-2030)
Figure 85. Global Therapeutic Vaccines Sales Market Share Forecast by Application (2025-2030)
Figure 86. Global Therapeutic Vaccines Revenue Market Share Forecast by Application (2025-2030)

Related Tags

Related Reports

payment cards

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted

Quick Contacts

Want to customize this report?

We offer 10% Free Customization at the time of purchase

Get Free Customization

I'm Available

Kavita Mehra

Kavita Mehra

Business Development Manager

Trusted Partners

NONWOVENS_INDUSTRY
FB
issuewire
Financial_Express
logo_yourstory
FB

Budget constraints? Get in touch with us for special pricing

Request Discount

Order Detail

  • Order Placed (28 April, 2026)
  • Notify To Team (28 April, 2026)
  • Report updation (29 April, 2026)
  • Report Quality Check (29 April, 2026)
  • Report Dispatch (30 April, 2026)

  • paypal
  • icici
  • stripe
  • wire-transfer

  • Email
  • Hard Copy

Research Methodology

An Adaptive Approach to Modern-day Research Needs

Get Methodology

Recently Viewed Products

Logo

Global Therapeutic Vaccines Market Growth 2024-2030

ChatGPT Summarize Gemini Summarize Perplexity AI Summarize Grok AI Summarize Copilot Summarize

Contact usWe are friendly and approachable, give us a call.

We uses Cookies

We use cookies to ensure you get the best experience on our website.